63 related articles for article (PubMed ID: 38690789)
1. Global burden of acute hepatitis E between 1990 and 2019 and projections until 2030.
Ouyang G; Pan G; Li Q; Li S; Liu T; Yi X; Liu Z
Liver Int; 2024 Jun; 44(6):1329-1342. PubMed ID: 38426633
[TBL] [Abstract][Full Text] [Related]
2. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
Whiteford HA; Degenhardt L; Rehm J; Baxter AJ; Ferrari AJ; Erskine HE; Charlson FJ; Norman RE; Flaxman AD; Johns N; Burstein R; Murray CJ; Vos T
Lancet; 2013 Nov; 382(9904):1575-86. PubMed ID: 23993280
[TBL] [Abstract][Full Text] [Related]
3. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Global Burden of Disease Study 2013 Collaborators
Lancet; 2015 Aug; 386(9995):743-800. PubMed ID: 26063472
[TBL] [Abstract][Full Text] [Related]
4. Infective Endocarditis in North Africa and the Middle East, 1990‒2019: Updates from the Global Burden of Disease Study 2019.
Malakan Rad E; Momtazmanesh S; Saeedi Moghaddam S; Rezaei N; Rezaei N; Jamshidi H; Naghavi M; Larijani B; Farzadfar F;
Arch Iran Med; 2024 May; 27(5):229-238. PubMed ID: 38690789
[TBL] [Abstract][Full Text] [Related]
5. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Diseases and Injuries Collaborators
Lancet; 2020 Oct; 396(10258):1204-1222. PubMed ID: 33069326
[TBL] [Abstract][Full Text] [Related]
6. The burden of childhood and adolescent cancers in North Africa and the Middle East (NAME) region: findings from the Global Burden of Disease study 2019.
Karimi A; Saeedi Moghaddam S; Azadnajafabad S; Esfahani Z; Sharifnejad Tehrani Y; Abbasi-Kangevari M; Shobeiri P; Ghamari SH; Masinaei M; Rezaei N; Shahin S; Rayzan E; Rezaei N; Larijani B; Kompani F
BMC Pediatr; 2023 Mar; 23(1):113. PubMed ID: 36890483
[TBL] [Abstract][Full Text] [Related]
7. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Risk Factor Collaborators
Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
[TBL] [Abstract][Full Text] [Related]
8. Global, regional and national burden of endocrine, metabolic, blood and immune disorders 1990-2019: a systematic analysis of the Global Burden of Disease study 2019.
Wu J; Lin X; Huang X; Shen Y; Shan PF
Front Endocrinol (Lausanne); 2023; 14():1101627. PubMed ID: 37223046
[TBL] [Abstract][Full Text] [Related]
9. Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017.
Gańczak M; Miazgowski T; Kożybska M; Kotwas A; Korzeń M; Rudnicki B; Nogal T; Andrei CL; Ausloos M; Banach M; Brazinova A; Constantin MM; Dubljanin E; Herteliu C; Hostiuc M; Hostiuc S; Jakovljevic M; Jozwiak JJ; Kissimova-Skarbek K; Król ZJ; Mestrovic T; Miazgowski B; Milevska Kostova N; Naghavi M; Negoi I; Negoi RI; Pana A; Rubino S; Sekerija M; Sierpinski R; Szponar L; Topor-Madry R; Vujcic IS; Widecka J; Widecka K; Wojtyniak B; Zadnik V; Kopec JA
PLoS One; 2020; 15(3):e0226766. PubMed ID: 32119685
[TBL] [Abstract][Full Text] [Related]
10. Global and Regional Trends and Projections of Infective Endocarditis-Associated Disease Burden and Attributable Risk Factors from 1990 to 2030.
Lin LJ; Liu YM; Qin JJ; Lei F; Wang WX; Huang XW; Liu WF; Zhang XY; She ZG; Zhang P; Zhang XJ; Jin ZX; Li HL
Chin Med Sci J; 2022 Sep; 37(3):181-194. PubMed ID: 36321173
[TBL] [Abstract][Full Text] [Related]
11.
Afeke I; Adu-Amankwaah J; Nyarko M; Bushi A; Ablordey AS; Duah PA; I Wowui P; Orish VN
Future Microbiol; 2022 Nov; 17():1335-1344. PubMed ID: 36111747
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device-Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017.
Khaloo P; Uzomah UA; Shaqdan A; Ledesma PA; Galvin J; Ptaszek LM; Ruskin JN
J Am Heart Assoc; 2022 Sep; 11(17):e025600. PubMed ID: 36000421
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019.
Ajam A; Shobeiri P; Keykhaei M; Moghaddam SS; Momtazmanesh S; Masinaei M; Esfahani Z; Rezaei N; Naderian M; Aminorroaya A; Rashidi MM; Rezaei N; Larijani B; Malakan Rad E; Farzadfar F
Int J Cardiol; 2022 Sep; 363():202-209. PubMed ID: 35777487
[TBL] [Abstract][Full Text] [Related]
14. Challenges and Updates in the Diagnosis and Treatment of Infective Endocarditis.
Sebastian SA; Co EL; Mehendale M; Sudan S; Manchanda K; Khan S
Curr Probl Cardiol; 2022 Sep; 47(9):101267. PubMed ID: 35636519
[TBL] [Abstract][Full Text] [Related]
15. Policy and strategies addressing prevention and control of antimicrobial resistance in Brazil: A scoping review protocol.
Nunes JO; Domingues RAS; Barcellos RMPC; Alves BMCS; Carvalho IPSF; Tavares NUL
PLoS One; 2022; 17(1):e0263305. PubMed ID: 35089973
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
